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West Nile virus (WNV) and chikungunya virus (CHIKV) are arboviruses that are constantly
(re-)emerging and expanding their territory. Both viruses often cause a mild form
of disease, but severe forms of the disease can consist of neurological symptoms,
most often observed in the elderly and young children, respectively, for which the
mechanisms are poorly understood. To further elucidate the mechanisms responsible
for end-stage WNV and CHIKV neuroinvasive disease, we used transcriptomics to
compare the induction of effector pathways in the brain during the early and late stage
of disease in young mice. In addition to the more commonly described cell death
pathways such as apoptosis and autophagy, we also found evidence for the differential
expression of pyroptosis and necroptosis cell death markers during both WNV and
CHIKV neuroinvasive disease. In contrast, no evidence of cell dysfunction was observed,
indicating that cell death may be the most important mechanism of disease. Interestingly,
there was overlap when comparing immune markers involved in neuroinvasive disease
to those seen in neurodegenerative diseases. Nonetheless, further validation studies are
needed to determine the activation and involvement of these effector pathways at the
end stage of disease. Furthermore, evidence for a strong inflammatory response was
found in mice infected with WNV and CHIKV. The transcriptomics profile measured in
mice with WNV and CHIKV neuroinvasive disease in our study showed strong overlap
with the mRNA profile described in the literature for other viral neuroinvasive diseases.
More studies are warranted to decipher the role of cell inflammation and cell death
in viral neuroinvasive disease and whether common mechanisms are active in both
neurodegenerative and brain infectious diseases.
Keywords: transcriptomics, Genomics, West Nile virus, chikungunya virus, neuroinvasive disease, cell death
mechanisms, immune response
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INTRODUCTION
Over the past decades, arboviruses such as West Nile virus
(WNV) and chikungunya virus (CHIKV) have emerged in
multiple countries across different continents, illustrating
their potential to pose a global public health threat. Although
infections with these viruses are usually benign, severe forms
of WNV and CHIKV infections may include neurologic
manifestations that are not well-understood. WNV and
CHIKV are arthropod-borne, enveloped, positive-sense RNA
viruses that belong to the family Flaviviridae and Togaviridae,
respectively. WNV is maintained in an enzootic transmission
cycle comprising birds, horses, and humans. Birds act as
amplification hosts and transmit the virus to mosquitoes,
predominantly Culex species, while humans and horses serve as
incidental dead-end hosts (Rossi et al., 2010). The transmission
cycle of CHIKV is mainly an urban mosquito-human cycle
involving anthropophilic Aedes mosquitoes; Aedes aegypti and
Aedes albopictus (Burt et al., 2012), but in West-Africa CHIKV
is maintained in a sylvatic cycle by sylvatic forest-dwelling
mosquitoes (Diallo et al., 1999).
Although human infections with WNV are asymptomatic in
the majority of cases, 20–30% may develop West Nile fever,
a mild flu-like illness consisting of symptoms such as malaise,
eye pain, headache, myalgia, gastrointestinal discomfort, and
rash. However, 1% of persons with clinical illness may develop
neuroinvasive disease such as meningitis, encephalitis, and acute
flaccid paralysis (AFP) (Campbell et al., 2002; Petersen and
Marfin, 2002), and long-term neurological sequelae, such as
persistent tremors and Parkinson-like disease, may present in
more than 50% of these cases. Patients with compromised
immune systems, the elderly, children, and people with
underlying conditions such as diabetes mellitus are especially at
risk of developing severe disease (Sejvar, 2014).
Clinical symptoms of CHIKV infection are characterized by
fever and rash, followed by myalgia and arthralgia (Dupuis-
Maguiraga et al., 2012). Chikungunya fever is rarely fatal with
symptoms resolving in weeks, but some patients suffer from
joint pain in the form of recurrent or persistent episodes that
can last for months to years (Ali Ou Alla and Combe, 2011).
Severe clinical manifestations of CHIKV infection often involve
the central nervous system (CNS) and occur most notably,
though not exclusively, in young children and the elderly, and
were commonly reported during the outbreaks in La Réunion
(Tournebize et al., 2009; Gerardin et al., 2016) and India
(Chandak et al., 2009; Lewthwaite et al., 2009; Peter et al., 2015).
WNV replicates in a wide variety of cell types and in vitro and
in vivo studies suggest that neurons and astrocytes in the CNS are
targeted (Shrestha et al., 2003; Cheeran et al., 2005; Diniz et al.,
2006; Hussmann et al., 2013; Lim et al., 2013). In contrast, it is
not clear whether CHIKVhas tropism for neurons and it has been
speculated that the neurological symptoms are instead the result
of infection of the choroid plexus and meninges (Couderc et al.,
2008). Studies using adult immunosuppressed AG129 mice did
not demonstrate infection of neurons (van den Doel et al., 2014),
while studies using adult severely immunosuppressed NRG mice
did show infection of neurons (Poo et al., 2014). In addition,
in vitro studies have shown that CHIKV infects both astrocytes
and neurons, while astrocytes were targeted in the brain of OF1
newborn mice (Das et al., 2015). Nonetheless, factors governing
the development of an immune response in the brain and the
causes of neurologic disease in both WNV- and CHIKV-infected
patients are poorly understood.
Even though the pathogenesis of WNV neuroinvasive disease
has not been fully elucidated, several studies have provided
evidence that apoptosis plays a central role during infection with
this virus in vitro and in mice (Parquet et al., 2001; Yang et al.,
2002, 2008; Chu and Ng, 2003; Kleinschmidt et al., 2007; Samuel
et al., 2007; Clarke et al., 2014b). CHIKV has also been shown
to induce apoptosis in vitro (Krejbich-Trotot et al., 2011a; Nayak
et al., 2017) and in vivo (Joubert et al., 2012), including in the
brain (Chiam et al., 2015) or in cells derived from the brain
(Dhanwani et al., 2012; Abraham et al., 2013). However, little is
known about the involvement of other programmed cell death
pathways, such as pyroptosis and necroptosis, in the pathogenesis
of WNV or CHIKV neuroinvasive disease. As programmed
cell death is a genetically controlled process, this suggests that
unraveling the mechanisms involved may support the design of
novel treatment protocols for WNV or CHIKV neuroinvasive
disease.
Apart from programmed cell death, conceptually, cellular
dysfunction may also contribute to the pathogenesis of
neuroinvasive disease. Cellular dysfunction is frequently the
result of mitochondrial dysfunction in which a deficit in energy
metabolism can damage the entire physiology of an organism
(Schon and Manfredi, 2003). Although progressive neuronal
loss most likely contributes to neurologic manifestations in
humans presenting with WNV neuroinvasive disease (Tselis and
Booss, 2014), it is possible that long-term sequelae may also
reflect dysfunction rather than loss of neurons. To date, cellular
dysfunction pathways have not yet been investigated for WNV.
The changing epidemiology of WNV and CHIKV, as well
as the constant risk of (re-)emerging virulent strains, highlight
the importance of understanding the underlying mechanisms
of severe WNV and CHIKV disease. As these mechanisms
can only be studied to a limited extent in human patients,
the mouse model is frequently used to study effector pathways
involved in meningitis/encephalitis. In addition, studying WNV
and CHIKV neurologic disease in a mouse model can help
unravel the effector mechanisms involved in viral pathogenesis,
such as cell dysfunction and/or cell death. Furthermore,
comparing inflammatory response markers during the late stage
of WNV and CHIKV neuroinvasive disease and those seen in
neurodegenerative diseases might help to unravel the possible
etiology of neurologic diseases, as well as potential common
treatments.
A sensitive tool for investigating pathogenesis is
transcriptome analysis, which has been used here to examine
gene expression changes as a result of WNV and CHIKV
infection, and to identify pathways that may be affected. Several
studies have been conducted that examine gene expression upon
WNV infection, such as in the brains of mice (Venter et al., 2005;
Clarke et al., 2014a; Kumar et al., 2016), in the thalamus and
cerebrum of experimentally infected horses (Bourgeois et al.,
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2011), as well as in human retinal pigment epithelium (hRPE)
cells (Munoz-Erazo et al., 2012). To date, however, no such
studies have been carried out for CHIKV.
In the present study, we have conducted a global
transcriptional analysis of the mouse brain in response to WNV
and CHIKV infection, in which we compared transcriptome
snapshots from animals with early and severe neuroinvasive
disease to identify putative pathways and mechanisms involved
in the end stage ofWNV andCHIKV pathogenesis. Furthermore,
we compared our findings to results from other studies that
conducted gene expression analyses in the brain after WNV
infection.
MATERIALS AND METHODS
Cells and Virus
Vero E6 cells were grown in DMEM (Lonza Benelux BV,
Breda, the Netherlands) supplemented with antibiotics (100 U
penicillin, 100µg/mL of streptomycin), 10% heat inactivated
fetal calf serum (FCS), 0.75% sodium bicarbonate, and 10 mM
hepes buffer (all from Lonza). Mice were infected with WNV
strain NY99 (accession AF196835.2, obtained from the Health
Protection Agency, Porton Down, UK; P5 on Vero E6 cells)
or CHIKV strain S27, accession AF369024). The 50% tissue
culture infectious dose (TCID50) was determined on Vero E6
cells using the Spearman & Kärber method based on the presence
of cytopathic effects 5 days post inoculation (Lim et al., 2013).
Mouse Infection
Nine-day old female C57/BL6 mice (Harlan Laboratories B.V.,
Venray, The Netherlands) were inoculated intraperitoneally
(i.p.) with either 105 TCID50/100µL of WNV-NY99 (n =
6) or 106.5 TCID50/100µL of CHIKV-S27 (n = 6). Mice
were sacrificed at the indicated time points (see Results
Section) in order to determine the kinetics of neuroinvasive
disease and perform transcriptomic analysis. For the kinetics
experiment, brains were collected in 1ml of DMEM containing
antibiotics (100U penicillin, 100µg/mL streptomycin) (right
hemisphere) or formalin (left hemisphere). For transcriptomic
analysis, cerebellum was separated from the brain and the
right hemisphere was gently washed once in ice-cold phosphate
buffered saline (PBS) and stored in RNAlater R© (Thermo Fisher
Scientific, Bleiswijk, The Netherlands) until further use.
In order to generalize the results obtained in young animals
to adult mice, female 6-week old C57/BL6 mice were infected
i.p. with 104 TCID50/100µL of WNV-NY99 (n = 8). Mice were
euthanized when humane endpoints were reached (immobility
and paralysis) between days 9 and 12 p.i. In addition, six animals
were inoculated with DMEM (control group) and euthanized
on day 2 after inoculation. Brains were collected and the right
hemisphere was stored in 1 mL of DMEM containing antibiotics
and stored at−80◦C until further processing.
Mice were maintained in isolator cages throughout the
infection experiment, had a 12 h day-night cycle and were fed ad
libitum. Animal experiments were approved by the Animal Ethics
Committee of Erasmus Medical Center under protocol number
122–11–01. Animals were euthanized by cervical dislocation
under isoflurane anesthesia.
Quantitation of Virus in the Brain
Half-brains in virus transport medium were homogenized and
RNA was isolated from 100 µL of homogenized tissue using
the MagNA Pure LC Total Nucleic Acid Isolation kit (Roche,
Almere, The Netherlands) and an automated nucleic acid
robotic workstation (Roche) according to the manufacturer’s
instructions. RNA copy numbers in the brain were determined
using the TaqMan R© EZ RT-PCR kit (Applied Biosystems,
Bleiswijk, The Netherlands) employing primers and probe
located on the 3′UTR for WNV, as previously described in Lim
et al. (2013), or primers and probe located on the E1 protein
for CHIKV (van den Doel et al., 2014). Viral RNA load was
determined from a standard curve and expressed as copies/gram.
Histology, Immunohistochemistry (IHC)
and Confocal Microscopy
After formalin fixation, tissues were dehydrated, embedded in
paraffin, and cut in 5 µm sections. Sections were deparaffinized
in xylene (Klinipath, Breda, the Netherlands), rehydrated in
descending concentrations of ethanol and pre-treated for optimal
antigen retrieval by boiling the slides for 20 min in 10 mM
citrate buffer (pH 6.0; Sigma, Zwijndrecht, the Netherlands).
Slides were cooled on ice for 30 min and endogenous peroxidase
(PO) was blocked with 3%H2O2 for 15min at room temperature.
For WNV, tissue sections were blocked for 1 h at room
temperature with 0.05% Tween20 and 5% rabbit serum in PBS
and subsequently incubated overnight with primary goat anti-
WNV non-structural protein 3 (NS3) antibody (1:100; R&D
Systems, Abingdon, UK) at 4◦C. For CHIKV, tissue sections
were blocked with 0.05% Tween20 and 5% goat serum in
PBS and incubated overnight with rabbit-anti-CHIKV capsid
(1:2,500) (van den Doel et al., 2014) at 4◦C. After washing,
slides were incubated with the secondary antibody [rabbit-anti-
goat IgG-PO antibody for WNV, and goat-anti-rabbit IgG-PO
for CHIKV (both 1:100, Dako, Eindhoven, The Netherlands)]
for 1 h at room temperature and developed with 3-amino-
9-ethyl carbazole (AEC, Sigma) substrate, counterstained with
Mayer’s hematoxylin and mounted with Kaiser’s glycerin-
gelatin. Screening of sections was done with an Olympus BX51
microscope coupled to a camera (objective 10x and 20x).
Messenger RNA Profiling
Total RNA was isolated from brain samples stored in RNAlater R©
using Trizol Reagent (Invitrogen, Breda, The Netherlands) and
the RNEasy Mini kit (Qiagen, Venlo, The Netherlands). RNA
concentrations and OD 260/280 ratios were measured with the
NanoDrop ND-1000 UV-VIS spectrophotometer (NanoDrop
Technologies, Wilmington, USA). Assessment of RNA quality
and purity was performed with the RNA 6000 Nano kit on the
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,
USA). RNA (200 ng) was labeled using the MessageAmp Premier
RNA Amplification kit (Applied Biosystems) and hybridized
to Affymetrix GeneChip R© Mouse 4302 Arrays (Affymetrix,
ThermoFischer Scientific, Bleiswijk, The Netherlands), according
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to the manufacturer’s recommendations. Image analysis was
performed using GeneChip Operating Software (Affymetrix).
Microarray Suite version 5.0 software (Affymetrix) was used to
generate .dat and .cel files for each experiment. The raw data was
deposited in ArrayExpress under access number E-MTAB-5832.
Microarray Processing and Analysis
Probe-level data was normalized using quantile normalization
and the transformed probe values were summarized into
probe set values by the median polish method (Gautier et al.,
2004). Probe set wise comparisons between the experimental
conditions were performed using limma (Phipson et al., 2016).
Correction for multiple testing was achieved by applying a false
discovery rate (FDR) of 0.05, calculated using the Benjamini-
Hochberg procedure (Benjamini and Hochberg, 1995). Further
downstream processing and interpretation of data including
principal component analysis (10,000 most variable probesets)
and limma analysis (Ritchie et al., 2015) was performed in R
version 3.3.1.
Curation of Gene Sets
To investigate the different effector pathways of interest,
a refined set of genes extensively curated from annotated
literature and biological databases was used. Literature
containing the keywords: genes, inflammatory molecules
in neurodegenerative diseases, pathways and cell death,
apoptosis, pyroptosis, necroptosis, autophagy, inflammasome,
mitochondrial dysfunction, and neuronal dysfunction, were
selected, including both normal and disease states from multiple
species. Throughout the annotated literature links to key genes
in a particular pathway were also used.
Gene Set and Meta-Analysis
Gene set analysis based on GOSlim (The Gene Ontology, 2017)
and Reactome (Fabregat et al., 2016) pathways was performed
using the quantitative self-contained geneset analysis method
“fry” from the limma package on probe sets mapped to ensemble
mouse identifiers. Results were visualized as heatmaps. Curated
gene set analysis and meta-analysis was performed on probe
sets mapped to MGI symbol. The curated gene sets were
tested for differential expression using the competitive gene set
testing approach “camera.” For meta-analysis, the overlap was
represented as the Fisher’s test odds ratio and 90% confidence
intervals. All mappings were performed using Ensembl 87
annotation. When multiple probe sets mapped to genes or
identifiers, the probe set with the highest median expression was
selected. All analyses were performed in R 3.3.1.
Quantitative Real-Time RT-PCR for
Validations
Results obtained from microarray data for WNV were verified
in an experiment using adult mice (WNV: n = 8; control: n =
6). Expression of 10 genes that were found to be differentially
expressed (DE) in the microarray analysis was validated by
qRT-PCR. These were as follows, for up-regulated genes:
Gzmb (Mm00442834_m1), Ubd (Mm01972246_s1), Ccl5
(Mm01302428_m1), Cxcl9 (Mm00434946_m1), Tnfaip2
(Mm00447578_m1), Lcn2 (Mm00809552_s1), and for
down-regulated genes: Mfge8 (Mm00500549_m1), Slc7a10
(Mm00502045_m1), Aplnr (Mm00442191_s1), and Map6
(Mm00447898_m1). The expression of three pyroptosis
markers (as indicated below) were also validated in the WNV-
infected adult mice. Gapdh (mM99999915_g1) was used as the
endogenous reference gene for normalization of target gene
expression.
Results obtained from microarray data for CHIKV were
verified with qRT-PCR using the extracted mRNA obtained for
transcriptomic analysis for a selection of six genes involved in
apoptosis and pyroptosis. The following markers were measured:
caspase-1 (Mm00438023_m1), caspase-3 (Mm01195084_m1),
caspase-9 (Mm00516563_m1), IL-18 (Mm00434225_m1), IL-
1β (Mm01336189_m1), and TNF-α (Mm00443259_g1). The
house-keeping gene β-actin (ACTB 4351315) was used as the
endogenous reference gene for normalization of target gene
expression. A house-keeping gene was selected when the CT-
values between the control and infected groups did not vary.
Purified RNA was converted to cDNA using Superscript III
and oligo dT primer (Invitrogen) according to the instructions
of the manufacturer. Expression of the different target genes
was determined using TaqMan R© Universal PCR Master Mix and
TaqMan Gene Expression Assay primer and probe (FAM-MGB)
sets (Applied Biosystems) on a 7500 Fast Real-Time PCR System
(Applied Biosystems) under the following conditions: activation
at 50◦C for 2 min followed by 95◦C for 10 min, and 40 cycles
of denaturing at 95◦C for 15 s and annealing at 60◦C for 1
min. Relative expression fold-change was calculated by the 2−1Ct
method and for WNV validations presented as the expression
ratio of the mean CT of WNV-infected over mock-infected mice.
Gene expression values were analyzed with a two-tailed, non-
parametric Mann-Whitney test (Graph Pad Prism version 6).
Values of P ≤ 0.05 were considered statistically significant.
RESULTS
Different Kinetics of WNV and CHIKV
Infections in Young Mice
To determine the time point at which virus was first detected in
the brain after peripheral inoculation (i.e., the early time-point)
and the onset of neuroinvasive disease (i.e., the late time-point),
a kinetics experiment was performed in young mice. For WNV,
mice were asymptomatic up to and including day 3 p.i. The
first signs of illness, such as lethargy, decreased mobility, and
balancing problems, appeared on day 4 p.i., and by day 5 and 6
these symptoms had progressed to moribund state and/or hind-
leg paralysis. Infection of the brain was confirmed at all the time
points tested (Figure 1A) using qRT-PCR. On day 3,∼105.4 RNA
copies were present in the brain, which increased to ∼107.4 on
day 4, 108.7 on day 5 and 109 RNA copies by day 6. Based on the
clinical presentation and viral RNA titers in the brain, day 3 was
chosen as the early time point (WNV-E) of infection and day 5 as
the late time point (WNV-L), at which themajority of the animals
had reached the humane end-point of the experiment. All mice
euthanized at the early and late time point in the subsequent
experiment were positive for virus in the brain with mean titers
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FIGURE 1 | Viral RNA titers found in the brain of WNV-infected mice determined during the (A) kinetics experiment, and (B) microarray experiment, as well as viral
RNA titers found in the brain of CHIKV-infected mice of the kinetics experiment (C), and in the cerebellum of mice used for the microarray (D). Viral titers are given as
copy numbers per gram of brain; error bars represent the standard deviation.
of∼105.6 and 109.2 RNA copies, respectively (Figure 1B). Mice of
the control group were negative for virus in the brain as expected.
For CHIKV, infected mice sacrificed on day 2 did not yet
display any clinical signs, while CNS involvement (tetanus-
like phenotype) was observed on day 3 in the majority of the
animals. Viral RNA was detected in brains collected on days
2, 3, and 4 (Figure 1C). Day 2 was selected as the early time
point of infection (CHIKV-E), while day 3, at which tetanus-
like manifestations (characterized by an inverse tetanus-like
posture) were observed, was considered as the late time point
(CHIKV-L). To determine if viral RNA was present in the
brains of infected mice, the cerebellum was tested and viral
RNA was detected in all mice euthanized on day 2 and 3
(Figure 1D).
Both WNV and CHIKV Infect Neurons in
Brains of Young Mice
Productive infection with WNV- and CHIKV was confirmed
by IHC staining using brain samples of the mice from the
kinetics experiment. A low amount of WNV-infected neurons
was demonstrated in the brains of mice at the early time point
(Figure 2A), whereas more extensive staining of neurons across
the brain was found at the late time point (Figure 2B), in line
with the qRT-PCR results.
IHC staining for CHIKV viral antigen revealed few positive
neurons in the brains of mice sacrificed on day 2 p.i. (Figure 2C),
while by day 3 p.i. the virus had spread extensively to other areas
of the brain (Figure 2D).
Differences in Differentially Expressed
Genes between the Early and Late Time
Points of Infection and between WNV and
CHIKV Infected Young Mice
To obtain an overall view of the effect of WNV and
CHIKV infection on the brain at the mRNA-level, we applied
the principal component analysis (PCA) to evaluate the
transcriptome profiles obtained at both early and late time
points (Figure 3A). For this analysis, the 10,000 most variable
probe sets were used and the results were depicted as a two-
dimensional plot. The first component, which explains 49% of
the variability in these probe sets, largely concurred with the
time since inoculation or progression of infection as it aligned
all the time points from control to 5 days p.i. The second
principal component (32% of variability) primarily separated the
WNV-L samples from the other groups. Taken together, PCA
transcriptome analysis is in line with the observation that the
early and late groups displayed a distinct clinical phenotype.
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FIGURE 2 | Representative staining of neurons with anti-WNV-NS3 in the brains of C57BL/6 mice euthanized on (A) day 3 (magnification 20×) and (B) day 5
(magnification 20×) of the kinetics experiment, and staining of neurons with anti-CHIKV-capsid in the midbrain of C57BL/6 mice euthanized on (C) day 2
(magnification 40×) and (D) day 4 (magnification 20×) of the kinetics experiment.
We compared the host transcriptional signatures in samples
collected early (CHIKV: day 2; WNV: day 3) and late (CHIKV:
day 3; WNV: day 5) during the infection process (Figures 3B,C).
In general, a larger number of genes were differentially expressed
(DE) as the infection progressed, both in WNV and in CHIKV.
By applying a fold change of≥2 and a FDR of<5%, we identified
87 and 1395 probe sets in CHIKV-E and CHIKV-L when
compared to the control, respectively (Figure 3B). The CHIKV-
E set was mostly a subset of the larger CHIKV-L signature. For
WNV, we identified 405 and 1007 DE probe sets when comparing
WNV-E andWNV-L to the control, respectively. The majority of
these probe sets were up-regulated and there was clear overlap
between the early and late signatures, but less than in CHIKV
(Figure 3C).
For the late vs. early comparisons, 390 genes were DE
for WNV and 310 genes for CHIKV, of which 199 genes
were uniquely DE for WNV and 119 for CHIKV (Figure 6B).
The top 10 most DE transcripts within the microarray
analysis were selected based on expression value (log ratio)
and are summarized in Tables 1, 2. Of the top 10 genes,
five up-regulated (Lcn2, Cxcl9, Tnfaip2, Ccl5, and Lilrb4)
and one down-regulated gene (Slc40a1) were found to be
common to both the WNV and CHIKV late vs. early
comparisons.
Subsequently, the biological processes reflected by the up-
regulated genes were identified (Figures 3D,E). The top DE
pathways for both CHIKV and WNV included up-regulation of
“immune system processes,” “response to stress,” and “symbiosis,
encompassing mutualism through parasitism,” which is a generic
gene set that also includes host-virus interactions. Other notable
DE gene sets included “cell proliferation,” “aging,” and “cell
death processes,” in particular at the late time points in both
CHIKV and WNV infection. When we compared late to early
transcriptome profiles, we observed the same processes to be up-
regulated, which shows that the infection progressed after day
3 p.i. (Figures 3D,E). In the comparison of the late-stage WNV
and CHIKV infection with the early-stage, the most significant
(in terms of P-value) gene ontology terms associated with up-
regulated genes included: “autophagy,” “immune system process,”
“transcription factor activity,” and “response to stress.” A full list
of GOslim terms associated with DE genes is shown in Table S1
in the Supplemental Material.
Although late-stage CHIKV infection resulted in a tetanus-
like phenotype distinct from WNV neuroinvasive disease, gene
set analysis of CHIKV showed that a set of pathways similar
to WNV is expressed at the late stage of disease, including up-
regulation of “response to stress,” “cell proliferation,” “immune
system processes,” and “lysosome process.”
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FIGURE 3 | Analysis of transcriptome profiles of brain tissue after infection with CHIKV and WNV. (A) PCA analysis showing the different infected groups and controls.
(B,C) Differentially expressed probe sets for early and late during CHIKV infection, and early and late during WNV infection, respectively. Up-regulated genes had a fold
change of ≥2 and a FDR of <0.05 shown as up (red) or down-regulated (green). (D,E) Quantitative gene set analysis using GOslim annotation for the indicated
contrasts. Up-regulated gene sets are indicated in red, down in green. The top-10 gene sets for every contrast are included in the heatmaps.
Differential Gene Expression Is Associated
with Immune Response Pathways in WNV
and CHIKV Infected Young Mice
To further characterize the immune processes present in mice
with neuroinvasive disease caused by infection with WNV
and CHIKV (late vs. early), we used immune pathways from
REACTOME to find pathways and processes that were altered
upon viral infection. Many of the highly expressed transcripts
were involved in innate and adaptive immunity. For instance,
the activation of the inflammatory response is dependent on
transcription factors such as NFκB, USF1, SP1, and FOX (i.e.,
FOXJ1, FOXN1, FOXO1, FOXP3), of which five were up-
regulated in theWNV-infected animals and seven in the CHIKV-
infected animals (late vs. early; Table S2). Many pathways
typically associated with viral infection were up-regulated early
and equally upon CHIKV and WNV infection, including
interferons, class I antigen presentation and complement
pathways. Pathogen-recognition receptors (PRRs) such as toll-
like receptors were up-regulated more strongly in WNV than
in CHIKV infection, both at early and late time points (Figure
S1). Generally speaking, similar pathways were found to be DE in
both WNV and CHIKV infections.
To better examine differences in inflammatory mediators
known to play a role in neurodegenerative diseases, we looked
closely at specific cytokines and chemokines and plotted their
fold changes relative to the control (Figure 4), and also compared
late vs. early (Tables S2, S4). Differential regulation of cytokines
and chemokines was observed between CHIKV and WNV,
both at the early and late time points. Fold changes tended
to be slightly higher in WNV infection compared to CHIKV,
but did typically involve the same mediators. Briefly, 7 of
12 genes encoding cytokines (Table S2) and 16 of 21 genes
encoding chemokines (Table S4) were differentially regulated in
WNV-L (vs. early), while 8 cytokine genes and 14 chemokine
genes were differentially regulated for CHIKV-L (Tables S1, S3).
Inflammatory molecules such as IL-6, IFN-γ, CCL-2, -3, -4, -
5, CXCL10, and CXCL2 were up-regulated in both WNV-L
and CHIKV-L (Figure 4, Tables S1, S3). In addition, the gene
expression of molecules that regulate the immune response, such
as TNFRSF1A, CXCR4, CD47, and MAPK12 was up-regulated
during WNV-L and CHIKV-L (compared to their early time
point) (Table S3).
Different Cell Death Pathways Are
Activated in Young Mice with
Neuroinvasive Disease
The pathogenesis of neuroinvasive disease is believed to be
the result of cell death but may also involve cell dysfunction.
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TABLE 1 | Top 10 most up-regulated genes as determined by log2 fold change in the brains of WNV- and CHIKV-infected mice for the late to early stage comparison.
WNV-L vs. E CHIKV-L vs. E
Symbol Entrez gene name Log2 fold
change
P-value Symbol Entrez gene name Log2 fold
change
P-value
Lcn2 Lipocalin 2 4.87 6.81E-10 Cxcl10 Chemokine (C-X-C motif) ligand 10 5.09 4.38E-13
Cxcl9 Chemokine (C-X-C motif) ligand 9 4.80 4.46E-11 Lcn2 Lipocalin 2 4.73 4.48E-09
Ubd Ubiquitin D 4.76 2.59E-17 Ccl5 C-C motif chemokine ligand 5 4.19 4.22E-10
Tnfaip2 TNF alpha induced protein 2 4.71 4.00E-13 Ifi204 Interferon activated gene 204 4.18 5.19E-11
Ccl5 C-C motif chemokine ligand 5 4.43 3.01E-11 Gbp2 Guanylate binding protein 2 4.13 1.34E-13
Gzmb Granzyme B 4.39 4.20E-15 Lilrb4 Leukocyte immunoglobulin like receptor 4 4.12 5.84E-11
Slfn12l Schlafen family member 12 like 4.07 1.39E-08 Acod1 Aconitate decarboxylase 1 4.08 6.77E-12
Ifnb1 Interferon beta 1 3.89 9.13E-16 Cxcl9 Chemokine (C-X-C motif) ligand 9 4.02 6.94E-09
Ccl13 C-C motif chemokine ligand 13 3.89 1.92E-13 Ms4a4b Membrane-spanning 4-domains, subfamily
A, member 4B
3.99 3.74E-08
Lilrb4 Leukocyte immunoglobulin like receptor B4 3.89 6.82E-11 Tnfaip2 TNF alpha induced protein 2 3.89 1.48E-10
TABLE 2 | Top 10 most down-regulated genes as determined by log2 fold change in the brains of WNV- and CHIKV-infected mice for the late to early stage comparison.
WNV-L vs. E CHIKV-L vs. E
Symbol Entrez gene name Log2 fold
change
P-value Symbol Entrez gene name Log2 fold
change
P-value
Aplnr Apelin receptor −2.46 1.04E-11 Gpr34 G-protein coupled receptor 34 −1.68 2.65E-08
Slc7a10 Solute carrier family 7 member 10 −2.26 1.56E-13 Slc40a1 Solute carrier family 40 member 1 −1.51 2.57E-12
Hbb-b2 Hemoglobin, beta adult minor chain −2.16 2.57E-09 Ednrb Endothelin receptor type B −1.48 7.32E-07
Hba1/Hba2 Hemoglobin subunit alpha 2 −2.09 3.76E-07 Idi1 Isopentenyl-diphosphate delta isomerase 1 −1.38 7.99E-05
Ca8 Carbonic anhydrase 8 −1.83 2.31E-07 Meg3 Maternally expressed 3 −1.35 0.0037
Nrarp NOTCH-regulated ankyrin repeat protein −1.77 3.03E-10 Gls Glutaminase −1.31 6.63E-06
Slc40a1 Solute carrier family 40 member 1 −1.74 4.29E-12 Zfp826 Zinc finger protein 826 −1.31 0.0022
Hes5 hes family bHLH transcription factor 5 −1.71 6.74E-11 P2ry12 Purinergic receptor P2Y12 −1.26 1.11E-09
Mfge8 Milk fat globule-EGF factor 8 protein −1.66 6.51E-13 Ttll1 Tubulin tyrosine ligase like 1 −1.25 5.66E-07
Map6 Microtubule associated protein 6 −1.62 5.47E-12 Hspa4l Heat shock protein family A (Hsp70)
member 4 like
−1.25 0.0048
Inflammation is known to be associated with dysfunction and
cell death, which we also observed in the generic gene set
analysis as the “cell death” pathways and many genes associated
with neurological disease were up-regulated (Figures 3D,E).
To pinpoint which of these processes are most prominent in
WNV and CHIKV infection of the brain and elucidate the
involvement of cellular dysfunction, we compared mitochondrial
and neuronal dysfunction curated gene sets (Tables S5, S6) to cell
death-related curated gene sets including apoptosis (Table S7),
pyroptosis (Table S8), and autophagy (Table S9). By using a
competitive gene set testing approach, we were able to establish
the gene sets that were most up-regulated relative to the
others (Figure 5A). The analysis indicated that neuronal and
mitochondrial dysfunction processes had less impact on the
transcriptome than the cell death pathways. Conversely, the cell
death pathways pyroptosis and apoptosis were highly enriched
at the late stage (WNV-L and CHIKV-L) when compared to
the early stage. Of the cell death pathways, apoptosis had the
strongest signature in both CHIKV-L and WNV-L compared to
early (Figure 5A).
Given the small set of genes currently known to be involved
in necroptosis, a competitive gene set testing approach could
not be carried out. However, four of the six genes important for
promoting necroptosis were found up-regulated in both WNV
and CHIKV neuroinvasive disease (WNV-L or CHIKV-L vs.
Ctrl; Table 3), of which three form the necroptosome (MLKL,
RIPK1, and RIPK3), a supra-molecular structure required for
further transduction of the necroptosis signal into mitochondria.
Up-regulation of components of this pathway was found to
progress from the early to the late stage in both viral infections.
Concurrent with the up-regulation of this pathway through
disease progression was also the up-regulation of inhibitors
of necroptosis, such as BIRC2 and BIRC3, indicating that the
pathway was most likely activated (Table 3).
Validation of Microarray Data by qRT-PCR
The gene expression of an almost equal selection of the top 10
most highly up- or down-regulated genes observed in youngmice
infected withWNV, and deemedmost relevant for viral infection,
immunology or for expression in the brain, was validated by
Frontiers in Microbiology | www.frontiersin.org 8 August 2017 | Volume 8 | Article 1556
Lim et al. Transcriptomics WNV- and CHIKV-Infected Mice
FIGURE 4 | Heatmap to show the relative enrichment of Reactome immune gene sets following a self-contained gene set test. Cytokine and chemokine expressions
are given relative to the median of the control samples.
qRT-PCR by using brains of adult mice infected with WNV and
euthanized at the severe stage of infection, and compared to the
brains of mock-infected mice. Out of the 10 validated genes,
all genes showed a similar direction of differential expression
as compared to the microarray, and therefore deemed as genes
relevant to WNV infection (Table 4).
In addition, as the role of apoptosis in the pathogenesis of
WNV has already been intensely investigated in the literature,
we only validated the differential regulation of the pyroptosis
markers in adult mice. In accordance with the microarray data,
two of the three markers, caspase-1 and IL-1β were found
to be upregulated by a log2 fold change of 3.21 and 1.64,
respectively (data not shown), suggesting potential involvement
of this pathway in adult mice with severe WNV disease
as well.
As CHIKV is not able to cause neuroinvasive disease in
(adult) immunocompetent mice, validations were conducted
on the same samples as the microarray analysis rather than
in another mouse model. Analyzing the expression of three
genes involved in apoptosis (caspase-3 and -9 and TNF-α;
Figure 5B) and three genes involved in pyroptosis (caspase-
1, IL-18 and IL-1β ; Figure 5C), an increase over time in
TNF-α mRNA levels (P = 0.02) was observed, whereas the
mRNA level of caspase-3 and -9 did not show any significant
increase or decrease over time. An increase in mRNA over
time was also observed for caspase-1 (P = 0.02), IL-18 (≥
0.05, not significant), and IL-1β (P = 0.03). This supports the
potential involvement of pyroptosis in CHIKV neuroinvasive
disease.
Overlap in Transcriptome Signatures of
Neuroinvasive Disease in Mouse Brains
after Viral Infection
To determine the similarity of the transcriptomic profiles of
WNV and CHIKV neuroinvasive disease in our study to other
viral models of neuroinvasive disease, the up- and down-
regulated genes in the brains of WNV and CHIKV infected
mice obtained in our study were compared to each other and
to transcriptome data from WNV, Japanese encephalitis virus
(JEV) and reovirus infections in the brain from the literature
(Clarke et al., 2014a; Kumar et al., 2016). To this end, all genes
were mapped to MGI symbols to allow for cross-referencing
between datasets. Comparing transcriptome profiles between
different studies is challenging given the diversity in results that
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FIGURE 5 | Cell death pathways investigated in WNV- and CHIKV-infected
mice. (A) Competitive gene set test results for curated gene sets of cell death
pathways found in WNV (left) and CHIKV (right) neuroinvasive disease. The
genes included in the genesets are provided in the supplementary material.
qRT-PCR validations of (B) apoptosis and (C) pyroptosis microarray data for
CHIKV. qRT-PCR was performed on bulk brain (cerebrum and cerebellum) of
CHIKV-S27 infected 9-day-old C57BL/6 mice euthanized on day 2 (n = 5) and
day 3 (n = 4) p.i. to assess caspase-3 (casp-3) and -9
(Continued)
FIGURE 5 | Continued
(casp-9) and TNF-α expression levels (apoptosis) and caspase-1 (casp-1),
IL-18, and IL-1β (pyroptosis) expression levels. Mouse β-actin (Actb) was used
as the housekeeping gene, and all data were expressed compared to Actb.
Each point in the graph represents the expression value for the corresponding
apoptosis marker of 1 sample. The mean is represented here as a black line.
*P ≤ 0.05, **P ≤ 0.01: statistically different (two-tailed, Mann-Whitney test).
presumably result from experimental and technical differences
between studies. Furthermore, any difference in kinetics between
datasets will also contribute to differential gene expression
between viruses. As a result, we focused on overlap within studies,
rather than between studies.
When we compared the transcriptional profiles of WNV
to those of CHIKV, we observed genes that were specific
to either WNV or CHIKV, but we also saw a large overlap
between differentially expressed genes (Figures 6A,B). Using
a euler diagram to depict the gene expression profiles from
Figure 6A (Figure 6E), we observed that the early time
points were practically subsets of the later time point gene
lists, demonstrating progressive infection for both viruses.
Additionally, the overlap between WNV and CHIKV was large
enough to conclude that in our experiments, the pathogenesis of
WNV and CHIKV in the brain at mRNA level was largely similar
(Figures 6A,B,E).
To further compare our results to other published studies, we
obtained the differentially expressed gene lists from the Clarke
et al. and Kumar et al. studies and mapped them to unique
MGI (Figures 6C,D). Using the Fisher’s test odds ratio and 95%
confidence intervals to enumerate the overlap between the sets of
DE genes, we evaluated the overlap in the response to different
virus infections. When the overlap between our results for WNV
and the Clarke et al. sets was compared (Figures 6C,F), reovirus
tended to have the largest overlap with our WNV signatures, for
both early and late, while the overlap between our and the Clarke
et al. WNV data was slightly smaller at both the early and late
time point (Figure 6F).
For CHIKV-E, no difference in overlap between the Clarke
et al. sets was observed at the early time point. At the late time
point, the overlap with Clarke et al. is smaller, but the overlap
with reovirus was the largest. Furthermore, our WNV signature
exhibited a larger overlap with the pathogenicWNV strain rather
than with the attenuated strain used by Kumar et al (Figure 6G).
As with the Clarke et al. overlap, the overlap with CHIKV-E was
larger than the overlap with CHIKV-L.
Taken together, the meta-analysis shows that ourWNV results
tended to have consistently high overlaps with the signature sets
from the selected literature studies, but that CHIKV induced
expression of a slightly different set of genes at the late time point
that limited its overlap with other sets.
DISCUSSION
WNV has had an increasing public health impact since its
emergence in the Western Hemisphere in 1999. Also the
emergence of CHIKV in the Pacific and the Americas had a
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TABLE 3 | Differential regulation of genes involved in necroptosis in WNV- and CHIKV-infected mice (log2fold change).
Necroptosis WNV-E vs.
Ctrl
WNV-L vs.
Ctrl
WNV-L vs.
WNV-E
CHIKV-E
vs. Ctrl
CHIKV-L vs.
Ctrl
CHIKV-L vs.
CHIKV-E
Symbol Entrez gene name Log2 fold
change
Log2 fold
change
Log2 fold
change
Log2 fold
change
Log2 fold
change
Log2 fold
change
CYLD CYLD lysine 63 deubiquitinase 0 0 0 0 −0.90 0
MLKL Mixed lineage kinase domain like pseudokinase 1.37 2.47 0 0 1.98 1.63
RIP1 (RIPK1) Receptor interacting serine/threonine kinase 1 0.19 1.22 1.00 0 0.62 0.69
RIP3 (RIPK3) Receptor interacting serine/threonine kinase 3 0 0.52 0.46 0 0.26 0.28
CFLAR (C-FLIP) CASP8 and FADD like apoptosis regulator 0.38 1.78 1.40 0 1.38 1.43
FADD Fas associated via death domain 0 0 0 0 0 0
BIRC2 (cIAP1) Baculoviral IAP repeat containing 2 0 0.97 1.09 0 0.30 0.44
BIRC3 (cIAP2) Baculoviral IAP repeat containing 3 0.59 2.64 2.05 0 1.69 1.65
TABLE 4 | Comparison of the gene expression of a selection of the top 10
differentially regulated genes with qRT-PCR data obtained from adult mice
infected with WNV.
Gene symbol Log2 fold change
Microarray analysis qRT-PCR
WNV-L vs. Ctrl WNV-L vs. Ctrl
Cxcl9 6.33 7.81
Ubd 5.21 3.41
Gzmb 4.89 7.08
Ccl5 6.23 7.81
Tnfaip2 5.82 2.93
Lcn2 6.12 4.17
Mfge8 −1.36 −2.27
Slc7a10 −2.02 −0.99
Aplnr −1.82 −1.01
Map6 −1.15 −1.65
Expression was normalized according to the house keeping gene GADPH by using the
2−1Ct method and are presented as the expression ratio of the mean CT of WNV-infected
over mock-infected mice.
tremendous impact on the affected populations. Both viruses
have caused neuroinvasive disease in high-risk patients, and
despite the progress in understanding the mechanisms of
neuroinvasive disease, the precise pathways that are active during
the late stage of WNV and CHIKV severe disease are not well-
established. In this study, we used transcriptomics to identify the
effector pathways operating during the late stage of WNV and
CHIKV neuroinvasive disease and we showed that several cell
death pathways are simultaneously activated in mice with severe
disease.
From a conceptual point of view, the pathogenesis of
WNV and CHIKV infection can be considered a branching
cascade where the virus simultaneously initiates multiple
pathological pathways that then collectively contribute to
neuronal death and dysfunction. For most triggers of neurologic
disease, which consist of either proteinopathy or infection,
multiple hypotheses exist regarding the mechanism(s) of
pathogenesis, including neuronal dysfunction and/or cell death.
It has been shown that common effector pathways are
triggered across multiple neurological (inflammatory) diseases,
such as inflammation (Glass et al., 2010; Amor et al.,
2014), apoptosis (Honig and Rosenberg, 2000; Mattson, 2000),
proteasome dysfunction (Dantuma and Bott, 2014), stress
responses (Kim et al., 2015; Scheper and Hoozemans, 2015),
mitochondrial dysfunction (de Castro et al., 2010), axonal
transport deficits (Millecamps and Julien, 2013), neuronal cell
cycle induction (Wang et al., 2009), pyroptosis (Guo et al.,
2015), autophagy (Ghavami et al., 2014), and necrosis (Troulinaki
and Tavernarakis, 2012). We sought to determine whether
pathways of programmed cell death and dysfunction were
activated during the late stage disease of WNV and CHIKV
infection.
To study and compare the response in the brain to infection
by these two viruses, we used nine-day old C57BL/6 mice in
which both WNV and CHIKV are able to cause neuroinvasive
disease. In order to identify the effector pathways differentially
expressed during severe disease it was important to compare
the late stage of disease with an early time point at which
virus was already present in the brain but mice were not
yet showing signs of neurologic disease. However, one caveat
in the comparison of transcripts between these two infection
models is the difference in the replication kinetics of the
respective viruses, as a valid comparison can only be built if
the kinetics of the viruses and corresponding host responses are
nearly identical. CHIKV replicates faster in vitro than WNV
(unpublished observations), which was “confirmed” in this study
by the fact that CHIKV entered the brain of infected mice earlier
and caused disease more rapidly than WNV. One way in which
we could have circumvented the different replication kinetics and
pathogenic mechanisms in the periphery and thereby improve
our evaluation of WNV- and CHIKV-induced gene expression
in the brain would have been by using intracranial inoculation.
Other experimental differences in our study between the two
virus models included viral inoculation dose and the virus
titers found in the brains of the mice. As a result, we only
compared the effector pathways observed in the animals at the
time that they were experiencing signs of severe neuroinvasive
disease.
Frontiers in Microbiology | www.frontiersin.org 11 August 2017 | Volume 8 | Article 1556
Lim et al. Transcriptomics WNV- and CHIKV-Infected Mice
FIGURE 6 | Overlap in differential expression signatures within datasets for our data (A,B,C) and Clarke et al. (C) and Kumar et al. (D). The overlap between our
CHIKV and WNV data is stated in (A), and schematically depicted in (E). The overlap between our data and the Clarke et al. (F) and Kumar et al. sets (G) is given by
the Fisher’s odds ratio and confidence intervals (bars).
Furthermore, the bulk brain was used to analyze the
transcriptomics of WNV- and CHIKV-infected mice. Although
the use of bulk brain may have reduced the resolution of the assay
and subsequently decreased the sensitivity for the identification
of effector pathways, we reasoned that infection of the brain with
both viruses would be extensive and still allow for identification
of prominent pathways in the late stage of infection. Even
though we have used quantitative gene set analysis techniques
that are highly sensitive, we may have missed identification
of certain pathways that were close to the background noise.
Furthermore, it is safe to assume that the (curated) pathways
and gene sets that we tested did not include all the relevant
molecules, even though the quality and quantity of gene sets is
increasing. Moreover, certain pathways make use of proenzymes
or immature proteins of which their activation cannot be
determined by gene expression.
Neuroinflammation and cell death have been shown to occur
in both infection and neurodegenerative diseases, indicating
that common effector pathways may be involved in neurologic
diseases. The mechanisms of neuronal injury following WNV
and CHIKV infection still remain incompletely characterized but
may be caused by direct cytolytic effect of the virus, programmed
cell death or immunopathology (Gosztonyi, 2001; Koyuncu et al.,
2013). In our study, we observed upregulation of apoptosis
markers in both WNV and CHIKV infected mice, and our
results are consistent with the transcriptome studies performed
in the brains of mice infected with WNV that show expression
of apoptosis markers such as caspase-4, -7, and -8 (Bourgeois
et al., 2011; Clarke et al., 2014a; Kumar et al., 2016). Furthermore,
infection of a range of cells in vitro as well as infection of mice
with other flaviviruses, such as St Louis encephalitis virus,Murray
Valley encephalitis virus and JEV, have also been shown to induce
apoptosis (Matthews et al., 2000; Parquet et al., 2002; Myint et al.,
2014), suggesting a central role for apoptosis in the pathogenesis
of viral encephalitis.
Furthermore, in our study we also observed differential
expression of the autophagy pathway in both infection models.
Autophagy is believed to be an important survival pathway
activated in response to infection; however, studies exist that
suggest either a protective (Joubert et al., 2012; Judith et al., 2013;
Kobayashi et al., 2014) or pathogenic role (Krejbich-Trotot et al.,
2011b) for autophagy during infection with WNV and CHIKV,
as well as limited involvement (Beatman et al., 2012; Vandergaast
and Fredericksen, 2012).
Despite intensive investigation of apoptosis, little research has
been done to understand the role of other cell death pathways
in the pathogenesis of WNV and CHIKV encephalitis. In this
study, we found evidence for pyroptosis involvement during
the later stage of disease for both WNV- and CHIKV-infected
mice, which was validated in adult mice infected with WNV.
Pyroptosis is an inflammatory form of programmed cell death
that also takes place in the CNS and involves the formation
of the pyroptosome or inflammasome, activation of caspase-1
and the subsequent release of the proinflammatory cytokines
IL-1ß and IL-18 (Chen et al., 2016). Caspase-1 and IL-18 have
also been shown to be produced in neurodegenerative diseases
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such as Alzheimer’s disease and Multiple sclerosis (Losy and
Niezgoda, 2001; Huang et al., 2004; Sutinen et al., 2012; Saco
et al., 2014). Evidence for pyroptosis has also been found in
viral diseases, such as dengue (Wu et al., 2013) and adenovirus
(Barlan et al., 2011) infections. Molecules important for forming
the inflammasome, such as NLRP3 and NLRC5 have been found
elevated in mouse brains infected with WNV-NY99 (Kumar
et al., 2016). In our study, these molecules, in addition to the
other aforementioned ones, were investigated and found to be
up-regulated in WNV and CHIKV severe disease (data not
shown), providing stronger evidence for the involvement of the
pyroptosis pathway.
Another cell death pathway, necroptosis, which is a
programmed form of necrosis or inflammatory cell death,
has to date not been fully investigated in the brain upon
infection with neurotropic viruses. A study by Liu et al. has
shown that intra-cerebroventricular injection of TNF-α led
to activation of RIP3-mediated necroptosis in hippocampal
neurons, demonstrating that this pathway is functional in the
brain (Liu et al., 2014). The observation that several components
of the necroptosis pathway were more up-regulated in our
microarray during the late stage of WNV and CHIKV infection
compared to the early stage suggests a potential role for this
pathway in the exacerbation of the outcome of neuroinvasive
disease. However, as genes can have many different functions
in multiple pathways and precise differences between different
types of cell death are not well-defined, we cannot state with
certainty that the pathways that we have identified in our study,
such as pyroptosis and necroptosis, indeed play an important
role in viral pathogenesis. As a result, future experiments
measuring activation of both the pyroptosis and necroptosis
pathway in both neuronal cell cultures and in the brains of adult
mice upon WNV infection, as well as concomitant elimination
experiments, should be carried out.
Although infection of a neuron often leads to cell death,
it is possible that a phase of dysfunction precedes this stage
of cell death. Using a curated set of genes, we did not find
evidence for neuronal or mitochondrial dysfunction in either the
WNV or the CHIKV infection model. However, we cannot rule
out that our curated pathways did not contain all the relevant
genes, nor that the analysis of bulk brain reduced the sensitivity
of detecting dysfunction, consequently influencing the results.
Furthermore, gene expression might not be the most suitable
method for detecting cellular dysfunction, and further studies
involving proteomics or IHC stainings may be more appropriate.
The transcript profiles obtained from mice during the late
stage of WNV and CHIKV infection indicated a strong pro-
inflammatory response, which is common during infection with
both viruses. Many differentially expressed genes, but also many
cytokines and immune pathways were found to be shared by
CHIKV and WNV infection. Similarly, using meta-analysis,
we observed a large overlap between our WNV and CHIKV
transcriptome signatures and reovirus, JEV, and a virulent and
avirulent strain of WNV, in particular at the early time points.
At the late time point, CHIKV tended to have a slightly
different profile when compared to other viruses, which suggests
that CHIKV could have somewhat distinct mechanisms of
pathogenesis and/or activated pathways as compared to the other
viruses.
Several molecules that increase the inflammatory response in
the brain, such as TNFRSF1A, CXCR4, CD47, and MAPK12,
were up-regulated in the brains of both WNV and CHIKV
infected mice. In addition, many transcription factors, such as
NFκB, USF1, and FOX important for promoting inflammation,
were found elevated in both our models. However, it is not clear
whether the inflammatory response triggered during infection
with WNV or CHIKV is an unsuccessful attempt to clear the
infection with no share in the pathogenesis process or causally
associated with disease. Even though it is very difficult to establish
causality between neuroinflammation and pathology in primarily
descriptive studies such as ours, there is circumstantial evidence
for a role of neuroinflammation in disease.
For example, an excessive or dysregulated inflammatory
response in the brain has been shown to be associated with
both biological and clinical features of non-infectious neurologic
disease (Gibney and Drexhage, 2013). Some cytokines such as
IL-1β and TNF-A may cause damage and death because of their
neurotoxic activity through elevated glutamate production. TNF-
A has in fact been implicated in neuronal death by damaging
mitochondria in neurons and increasing the production of ROS.
Although TNF-A was highly up-regulated in our study, no effect
was seen in terms of mitochondrial dysfunction. Instead, it is
possible that the effect on the mice in our study was restricted
tomitochondria-induced apoptosis rather than dysfunction. Also
chemokines were found to be highly up-regulated in our study
during WNV and CHIKV infection, which are able to induce
neuronal death directly through the activation of neuronal
chemokine receptors or indirectly through the activation of
microglial killing mechanisms.
Neurodegeneration has been linked to several mediators, such
as IL-1β, IL-6, IL-8, IL-33, TNF-α, CCL2, CCL5, MMPs, reactive
oxygen species (ROS), CD40, CD40L, CD88, and MAPKs (Ke
et al., 2005; Ager et al., 2010; Glass et al., 2010; Kim and
Choi, 2010; Kim and Joh, 2012; Amor et al., 2014; Skaper
et al., 2014; Kempuraj et al., 2015). As we were interested in
determining whether the inflammatory response during the late
stage of WNV and CHIKV neuroinvasive disease is similar to
that seen in neurodegenerative diseases, we specifically compared
our data with such known mediators. In line with what has
been found in several neurodegenerative diseases, many of these
inflammatory mediators were found differentially regulated in
our study, including CXCL10, a chemokine shown to induce
apoptosis in fetal neurons (Sui et al., 2004). Taken together, these
mediators may provide the link between inflammation and cell
death.
Frasier et al. analyzed protein expression during the late
and early phase of neuroinvasive disease of mice infected with
WNV and CHIKV using 2D-DIGE and iTRAQ analysis (Fraisier
et al., 2013). Comparing the late time point with the early for
WNV, they were able to detect up-regulation of a few proteins,
including Cbr1, Hspa2, Vps45, Hba-a1, Ranbp3 and Ahsg, as
well as down-regulation of Crmp1 and Araf. These findings are
not entirely supported by our gene expression results, however,
as Crmp1 was the only detected protein that corresponded with
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our gene expression results. Nonetheless, this discordance is
most likely caused by the difference in kinetics of mRNA and
protein expression as they are often not highly correlated due to
the influence of, for example, post-transcriptional/translational
regulations.
In conclusion, this study provides evidence for the
involvement of cell death pathways such as apoptosis and
pyroptosis during WNV and CHIKV neuroinvasive disease,
with some evidence of involvement of necroptosis during
WNV severe disease. In addition, a strong inflammatory
response was found in mice infected with WNV and CHIKV,
as well as some overlap with inflammatory markers found in
neurodegenerative diseases. Additional in vitro and in vivo
studies should be conducted to further validate activation of cell
death pathways during infection, including autophagy, as well
as their contribution to the outcome of neuroinvasive disease.
Identifying pathways or markers of viral neuroinvasive disease,
which overlap with other non-infectious neurodegenerative
diseases, may be useful for finding potential targets for treatment
of neurologic diseases.
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